New York is set to gain 1,000 new biotech jobs as Regeneron Pharmaceuticals plans a $2 billion expansion in Saratoga Springs, marking one of the state’s biggest life sciences investments in years.
The New York-founded biotech company will redevelop more than one million square feet of space on Duplainville Road—formerly used for printed materials—into a major new manufacturing facility. The project will double Regeneron’s production capacity in the state and includes room for further growth.
The state’s economic development arm, Empire State Development, is backing the expansion with up to $35 million in performance-based tax credits through the Excelsior Jobs Program.
Founded in New York City in 1988, Regeneron has become the state’s largest biotech firm and one of the most productive in the world. Its Saratoga Springs facility will help manufacture life-saving medications, support drug development in areas like oncology and infectious diseases, and contribute to the state’s growing life sciences ecosystem.
Beyond the 1,000 full-time positions, the project is expected to create roughly 500 short-term design and construction jobs.
Boost for the Capital Region
Local and state officials hailed the project as a major win for the Capital Region’s economy and talent pipeline. Regeneron executives said the decision to expand in Saratoga was driven by access to skilled labor and strong community support.
“This investment is a powerful vote of confidence in the Capital Region’s workforce and economic momentum,” said Mark Eagan, CEO of the Center for Economic Growth.
The facility will occupy the former Quad Graphics building and stands to be one of Saratoga County’s largest commercial investments—second only to the $15 billion GlobalFoundries development.
Part of a broader biotech push
The project builds on a series of life sciences investments across New York. That includes the new $98 million Roswell Park cell therapy facility in Buffalo and the planned $430 million BioGenesis Park on Long Island.
These initiatives reflect the state’s strategy to position itself as a national leader in biotech, with strong infrastructure, research institutions, and a highly educated workforce.
Governor Kathy Hochul has emphasized this agenda with new advisory boards, industry partnerships, and public-private funding efforts.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].